First, in clinical practice, the phenotypes should contribute to further individualize the prognosis in the expected course, complementing other established prognostic factors such as the ALS progression rate, NfL, body mass index, or respiratory parameters. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.